SCHEMBL3765865

SCHEMBL3765865

CC1(C)Cc2c(sc(N3CCOCC3)c2-c2ccnc(-c3cccc(CN4CCNCC4)c3)c2)C(=O)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 1/20 0.37
MAPKAPK2 P49137 1/20 0.37
PSMB8 P28062 1/20 0.36
PIK3CD O00329 2/20 0.35
PIK3CG P48736 2/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
CHRM3 P20309 7/20 0.34
TGFBR1 P36897 2/20 0.33
CHEK1 O14757 2/20 0.33
KIT P10721 1/20 0.33
JAK2 O60674 1/20 0.33
JAK3 P52333 1/20 0.33
LCK P06239 1/20 0.33
YES1 P07947 1/20 0.33
LYN P07948 1/20 0.33
HCK P08631 1/20 0.33
FGR P09769 1/20 0.33
SRC P12931 1/20 0.33
EPHA3 P29320 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766694 0.89 CXCR4 (0.38) CXCR4MAPKAPK2PSMB8PIK3CDPIK3CG
SCHEMBL3761788 0.88 HTR7 (0.41) PIK3CDPIK3CGPIK3CAPIK3CBCHEK1
SCHEMBL3757522 0.87 PIK3CD (0.40) PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL3763305 0.86 CXCR4 (0.42) CXCR4MAPKAPK2PSMB8CHRM3TGFBR1
SCHEMBL3762152 0.86 MTOR (0.38) PIK3CDPIK3CGPIK3CAPIK3CBTGFBR1
SCHEMBL3760314 0.85 PIK3CD (0.42) MAPKAPK2PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL3760006 0.84 PRKDC (0.39) PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL3765884 0.84 PRKDC (0.41) MAPKAPK2PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL3765967 0.84 PIK3CA (0.36) MAPKAPK2PIK3CDPIK3CGPIK3CAPIK3CB
SCHEMBL3760623 0.83 PSMB8 (0.41) MAPKAPK2PSMB8PIK3CDPIK3CGPIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA CXCR4 2879/4885MAPKAPK2 53/4885PSMB8 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.